ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.
作者信息
Schouten Thijs J, Daamen Lois A, van Santvoort Hjalmar C, Molenaar I Quintus
机构信息
Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, Utrecht, Netherlands.
出版信息
Ann Surg Oncol. 2022 Sep;29(9):6000-6001. doi: 10.1245/s10434-022-11738-3. Epub 2022 Apr 19.
Abstract
摘要
相似文献
1
ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.美国外科医师学会作者反思：改进第8版美国癌症联合委员会胰腺导管腺癌切除TNM分期系统的必要性。
Ann Surg Oncol. 2022 Sep;29(9):6000-6001. doi: 10.1245/s10434-022-11738-3. Epub 2022 Apr 19.
2
Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.验证美国癌症联合委员会第 8 版胰腺导管腺癌分期系统。
Eur J Surg Oncol. 2019 Nov;45(11):2159-2165. doi: 10.1016/j.ejso.2019.06.002. Epub 2019 Jun 3.
3
Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.优化第八版 AJCC TNM 分期系统用于可切除胰腺导管腺癌。
Future Oncol. 2019 Oct;15(30):3457-3465. doi: 10.2217/fon-2019-0264. Epub 2019 Aug 28.
4
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.第八版美国癌症联合委员会（AJCC）TNM 分期系统在可切除胰腺癌患者中的国际验证。
JAMA Surg. 2018 Dec 1;153(12):e183617. doi: 10.1001/jamasurg.2018.3617. Epub 2018 Dec 19.
5
Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.为美国癌症联合委员会可切除胰腺导管腺癌分期配备肿瘤分级：递归划分分析
Med Oncol. 2016 Nov;33(11):122. doi: 10.1007/s12032-016-0839-4. Epub 2016 Oct 11.
6
ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：肿瘤沉积物在切除的胰腺导管腺癌中的预后价值。
Ann Surg Oncol. 2023 May;30(5):3045. doi: 10.1245/s10434-023-13109-y. Epub 2023 Jan 25.
7
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：部位重要吗？肿瘤位置对切除的胰腺导管腺癌病理特征、复发及生存的影响
Ann Surg Oncol. 2020 Oct;27(10):3913-3914. doi: 10.1245/s10434-020-08572-w. Epub 2020 May 12.
8
Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade.通过改良分期分组和增加肿瘤分级对可切除胰腺癌进行精细预后分期。
Eur J Surg Oncol. 2022 Jan;48(1):113-120. doi: 10.1016/j.ejso.2021.07.020. Epub 2021 Jul 26.
9
Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer.全国范围内验证第 8 版美国癌症联合委员会 TNM 分期系统和 5 项针对可切除胰腺癌的修改建议。
Ann Surg Oncol. 2022 Sep;29(9):5988-5999. doi: 10.1245/s10434-022-11664-4. Epub 2022 Apr 25.
10
ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?ASO作者反思：复发的不同模式会影响接受手术切除的胰腺导管腺癌患者的预后吗？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):806-807. doi: 10.1245/s10434-018-6820-z. Epub 2018 Oct 8.
本文引用的文献
1
Response to: Commentary on: "Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer".回应：关于《美国癌症联合委员会第八版癌症TNM分期系统在全国范围内的验证以及对切除胰腺癌的五项拟议修改》的评论
Ann Surg Oncol. 2022 Oct;29(11):7079-7080. doi: 10.1245/s10434-022-12168-x. Epub 2022 Aug 4.
Zotero 插件